Prevention of Recurrent Hepatitis B After Liver Transplantation
N/A
13 Years
N/A
13 Years
N/A
Not Enrolling
Both
Hepatitis B, Cirrhosis, Acute Liver Failure, Hepatocellular Carcinoma
Both
Hepatitis B, Cirrhosis, Acute Liver Failure, Hepatocellular Carcinoma
Trial Information
Prevention of Recurrent Hepatitis B After Liver Transplantation
Inclusion Criteria
- Patients awaiting or had received liver or combined liver-kidney transplantation for
hepatitis B including hepatitis B cirrhosis, hepatitis B liver cancer and fulminant
hepatitis B.
Type of Study:
Observational
Study Design:
N/A
Authority:
United States: Federal Government
Study ID:
NIH HBV-OLT (completed)
NCT ID:
NCT00059267
Start Date:
June 2001
Completion Date:
Related Keywords:
- Hepatitis B
- Cirrhosis
- Acute Liver Failure
- Hepatocellular Carcinoma
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis, Chronic
- Liver Cirrhosis
- Fibrosis
- Liver Failure
- Liver Failure, Acute
- Carcinoma, Hepatocellular
Name | Location |
|---|---|
| University of Michigan | Ann Arbor, Michigan 48109-0624 |
